Oppenheimer Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$891K Buy
57,613
+2,147
+4% +$33.2K 0.01% 768
2025
Q1
$825K Sell
55,466
-3,585
-6% -$53.3K 0.01% 760
2024
Q4
$782K Sell
59,051
-138,148
-70% -$1.83M 0.01% 779
2024
Q3
$2.8M Sell
197,199
-56,430
-22% -$802K 0.03% 457
2024
Q2
$3.28M Buy
253,629
+22,979
+10% +$297K 0.04% 407
2024
Q1
$3.2M Buy
230,650
+13,586
+6% +$189K 0.05% 367
2023
Q4
$3.1M Sell
217,064
-26,521
-11% -$378K 0.04% 406
2023
Q3
$3.77M Sell
243,585
-6,175
-2% -$95.5K 0.06% 338
2023
Q2
$3.92M Sell
249,760
-4,120
-2% -$64.7K 0.06% 336
2023
Q1
$4.18M Sell
253,880
-9,538
-4% -$157K 0.06% 304
2022
Q4
$4.11M Sell
263,418
-30,548
-10% -$477K 0.07% 310
2022
Q3
$3.81M Sell
293,966
-1,044
-0.4% -$13.5K 0.07% 293
2022
Q2
$4.14M Sell
295,010
-15,440
-5% -$217K 0.07% 293
2022
Q1
$4.45M Buy
310,450
+21,926
+8% +$314K 0.06% 317
2021
Q4
$3.93M Sell
288,524
-131,993
-31% -$1.8M 0.05% 359
2021
Q3
$6.89M Sell
420,517
-21,490
-5% -$352K 0.1% 243
2021
Q2
$7.44M Buy
442,007
+62,104
+16% +$1.05M 0.11% 224
2021
Q1
$6.94M Buy
379,903
+33,858
+10% +$618K 0.11% 220
2020
Q4
$6.3M Buy
346,045
+25,302
+8% +$460K 0.11% 230
2020
Q3
$5.72M Sell
320,743
-8,478
-3% -$151K 0.11% 214
2020
Q2
$5.9M Sell
329,221
-62,667
-16% -$1.12M 0.12% 201
2020
Q1
$5.95M Sell
391,888
-34,914
-8% -$530K 0.15% 168
2019
Q4
$8.42M Sell
426,802
-19,047
-4% -$376K 0.18% 140
2019
Q3
$7.67M Buy
445,849
+7,825
+2% +$135K 0.17% 152
2019
Q2
$7.75M Buy
438,024
+53,616
+14% +$949K 0.17% 146
2019
Q1
$7.83M Buy
384,408
+74,247
+24% +$1.51M 0.18% 146
2018
Q4
$5.22M Buy
+310,161
New +$5.22M 0.13% 190